Primary leptomeningeal melanomatosis successfully treated with PD-1 inhibitor pembrolizumab: A case report

RATIONALE: Primary leptomeningeal melanoma is an extremely rare disease of the central nervous system. There are no standard treatment protocols with a poor prognosis in very few reported cases. Immunotherapy in primary brain melanoma has not been successfully applied so far. PATIENT CONCERNS: We de...

Descripción completa

Detalles Bibliográficos
Autores principales: Misir Krpan, Ana, Rakusic, Zoran, Herceg, Davorin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738128/
https://www.ncbi.nlm.nih.gov/pubmed/33327228
http://dx.doi.org/10.1097/MD.0000000000022928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738128/
https://www.ncbi.nlm.nih.gov/pubmed/33327228
http://dx.doi.org/10.1097/MD.0000000000022928

Ejemplares similares